This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Inter Parfums' (IPAR) Alliances To Put Stock On Growth Trajectory
by Zacks Equity Research
Inter Parfums (IPAR) is on track to expand its business through new licenses or acquisitions. Also, the company's product launches keep it well placed.
Is Nu Skin Enterprises (NUS) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Coty (COTY) Up More Than 10% in 6 Months: More Room for Growth?
by Zacks Equity Research
Coty (COTY) has been gaining from its six core priorities and prudent alliances. The company's solid products and brands have been aiding, while cost inflation and supply-chain woes hurt.
Nu Skin (NUS) Up More Than 15% in 6 Months: Here's Why
by Zacks Equity Research
Nu Skin (NUS) is benefiting from technological advancements and strategic product programs. Management is optimistic about its Nu Vision 2025 strategy.
Kimberly-Clark (KMB) Faces High Costs, Down Over 10% in 3 Months
by Zacks Equity Research
Kimberly-Clark (KMB) is battling high input costs for the past few quarters. Soft sales in the company's Consumer Tissue segment are also a concern.
Philip Morris (PM) Takes Bold Steps to Cut Operations in Russia
by Zacks Equity Research
Philip Morris (PM) discontinues several cigarette products it offered Russia. It has also canceled all product launches, which were planned for 2022, in Russia among other steps.
Why Nu Skin Enterprises (NUS) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Nu Skin (NUS) Down 15.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nu Skin's (NUS) Effective Growth Efforts & Product Launches Aid
by Zacks Equity Research
Nu Skin (NUS) is optimistic about its Nu Vision 2025 strategy to become the world's leading integrated beauty and wellness company, driven by a dynamic affiliate opportunity platform.
McCormick (MKC) Suspends Russian Operations Amid Conflict
by Zacks Equity Research
McCormick (MKC) suspends operations in Russia after stopping advertising and promotional activity as well as other investments in the country.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Nu Skin (NUS) Q4 Earnings Beat Estimates, Revenues Down
by Zacks Equity Research
Nu Skin's (NUS) fourth-quarter 2021 earnings and revenues decline year over year. Management offers a drab view for the first quarter.
Nu Skin Enterprises (NUS) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 16.84% and 2.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nu Skin (NUS) Shines on Solid Sales Leaders & Customer Network
by Zacks Equity Research
Nu Skin Enterprises (NUS) has been benefiting from its efforts to empower sales leaders and strengthen the customer base.
Inter Parfums (IPAR) Up More Than 40% in 6 Months: Here's Why
by Zacks Equity Research
Inter Parfums (IPAR) is benefiting from its focus on business expansion through new licenses. The company is also on track with effective product launches.
Coty (COTY) Gains on Strategic Pillars & Solid Brand Portfolio
by Zacks Equity Research
Coty (COTY) has been benefiting from its six strategic pillars. Solid e-commerce performance and gains from alliances and agreements have been working well for the company.
Is Nu Skin Enterprises (NUS) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Helen of Troy (HELE) Poised on Leadership Brands, Strategies
by Zacks Equity Research
Helen of Troy (HELE) is focused on making investments in its Leadership Brands. Management is progressing well with key growth areas under its Phase II Transformation efforts.
Service Corporation (SCI) Up on Solid Cemetery Unit, Expansions
by Zacks Equity Research
Service Corporation (SCI) is benefiting from robust revenues in its Cemetery segment. Also, the company's strategic investments are driving growth.
Zacks.com featured highlights include: Nu Skin Enterprises, Caleres Inc., Preferred Apartment Communities, Inc., Schneider National and MDU Resources Group
by Zacks Equity Research
Nu Skin Enterprises, Caleres Inc., Preferred Apartment Communities, Inc., Schneider National and MDU Resources Group are included in this blog.
The Estee Lauder Companies (EL) Gains 38% in a Year: Here's Why
by Zacks Equity Research
The Estee Lauder Companies' (EL) Skin Care portfolio has been performing well for a while now. The company's online operations also look impressive.
Tap These 5 Low Price-to-Sales Stocks to Get Standout Returns
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks incurring losses or are in an early development cycle. Stocks like NUS, CAL, APTS, SNDR and MDU hold promise.
Here's Why Hold Strategy is Apt for Newell (NWL) Stock Now
by Zacks Equity Research
Newell (NWL) is poised for growth on solid demand, product innovation, e-commerce growth, and robust core sales growth. Cost inflation and supply-chain issues remain headwinds.
Nu Skin Enterprises (NUS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Nu Skin Enterprises (NUS) closed at $50.75, marking a -0.65% move from the previous day.